The basal forebrain is a critical complex of nuclei located in the ventral telencephalon that plays essential roles in arousal, attention, learning, and memory. This region contains the brain's major cholinergic projection system, providing the principal source of acetylcholine to the cortex, hippocampus, and amygdala. The basal forebrain cholinergic system is among the earliest and most severely affected regions in Alzheimer's disease, making it a crucial therapeutic target for neurodegenerative research [1]
The basal forebrain comprises several distinct nuclei organized along a rostral-caudal axis [2]
The medial septum (MS) is the most rostral component of the basal forebrain cholinergic system. Located in the midline of the ventral forebrain, the MS contains cholinergic (Ch1), GABAergic, and glutamatergic neurons that project primarily to the hippocampus via the septohippocampal pathway [3]
Key features:
The diagonal band of Broca consists of two limbs that arch beneath the anterior commissure [4]
The nucleus basalis of Meynert (NBM) is the largest and most important component of the basal forebrain cholinergic system. Located in the substantia innominata, the NBM contains approximately 200,000 large cholinergic neurons that provide the bulk of cortical cholinergic innervation [5]
The substantia innominata is a region in the basal forebrain that contains the NBM as well as scattered neurons that project to the amygdala and other limbic structures [6]
The basal forebrain cholinergic system is classified into distinct sectors (Ch1-Ch6) based on projection patterns [7]
| Sector | Nucleus | Primary Target | Function |
|---|---|---|---|
| Ch1 | Medial Septum | Hippocampus | Memory, theta rhythm |
| Ch2 | Vertical Diagonal Band | Hippocampus | Memory, plasticity |
| Ch3 | Horizontal Diagonal Band | Olfactory Bulb | Olfaction |
| Ch4 | Nucleus Basalis of Meynert | Neocortex | Attention, arousal |
| Ch5 | Pedunculopontine Nucleus | Thalamus | Arousal, REM sleep |
| Ch6 | Laterodorsal Tegmental Nucleus | Thalamus | Arousal, reward |
Basal forebrain cholinergic neurons are characterized by [8]
The basal forebrain cholinergic system plays a fundamental role in cortical activation and attention [9]
Mechanisms of action:
The septohippocampal cholinergic system from the medial septum and diagonal band is essential for [10]
Basal forebrain cholinergic projections to the cortex mediate [11]
The basal forebrain cholinergic system undergoes some of the earliest and most severe degeneration in Alzheimer's disease [12]
Timeline of degeneration:
Several mechanisms contribute to basal forebrain cholinergic degeneration in AD [13]
The cholinergic deficit in AD manifests as [14]
Several therapeutic strategies target the basal forebrain cholinergic system [15]
The main FDA-approved treatments for AD enhance cholinergic transmission:
Current cholinergic therapies have significant limitations [16]
Experimental approaches aim to replace lost cholinergic neurons [17]
Supporting surviving cholinergic neurons [18]
New approaches aim to develop disease-modifying therapies [19]
The basal forebrain integrates with multiple brain systems [20]
Mesulam et al. Cholinergic neurons of the basal forebrain in AD (1983). 1983. ↩︎
Spanaki et al. Basal forebrain cholinergic system: anatomy and function (2006). 2006. ↩︎
Buzsáki & Moser, Memory, navigation and theta rhythm (2013). 2013. ↩︎
Mesulam et al. Cholinergic projections from MS and DBB (1992). 1992. ↩︎
Geula & Mesulam, Nucleus basalis cholinergic neurons in AD (1994). 1994. ↩︎
Aggleton et al. Substantia innominata and memory (2015). 2015. ↩︎
Mesulam et al. Cholinergicinnervation from basal forebrain (2004). 2004. ↩︎
Hasselmo & Sarter, Cholinergic signaling in cortex (2011). 2011. ↩︎
Sarter et al. Basal forebrain attention circuitry (2005). 2005. ↩︎
Blusztajn & Berse, Hippocampal acetylcholine and memory (2000). 2000. ↩︎
Picciotto et al. Acetylcholine as a neuromodulator (2012). 2012. ↩︎
Schliebs & Arendt, Cholinergic system in AD progression (2011). 2011. ↩︎
Ballinger et al. Basal forebrain degeneration in AD (2016). 2016. ↩︎
Mufson et al. Cholinergic system in AD therapy (2008). 2008. ↩︎
Poirier et al. Cholinergic therapy limitations (2011). 2011. ↩︎
Mandel et al. Cell transplantation for basal forebrain (2007). 2007. ↩︎
Tuszynski et al. NGF gene therapy for AD (2005). 2005. ↩︎
Cuello & Bruno, p75NTR and cholinergic neurons (2007). 2007. ↩︎
Zaborszky et al. Basal forebrain distributed network (2012). 2012. ↩︎